Muscle health and heart device risk study
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how muscle health affects the risk of sudden cardiac death in people getting a heart device (ICD). It may help doctors better predict risks and tailor care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Getting your first implantable cardioverter-defibrillator (ICD), including a type that also helps the heart beat in sync (CRT-D)
- Willing to have a muscle health assessment (sarcopenia) before the procedure
- Willing to be followed over time and sign a consent form
- No history of heart valve problems (like mitral stenosis, valve replacement or repair)
- No prior ICD of the subcutaneous or extra-vascular type
- No other conditions that affect muscle metabolism, such as cancer or severe liver or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.
This study tests heart imaging (using MRI) to better identify factors linked to sudden cardiac death risk. You may be eligible if you have reduced heart pumping ability and are planning a specific heart device to prevent dangerous heart rhythms.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This study uses a special heart MRI to look at scar tissue after a heart attack and see if it can help predict who might need a device to prevent sudden cardiac arrest. It is for people who had a heart attack at least a month ago and had a cardiac MRI at Anzhen Hospital.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
This study helps doctors identify which heart attack survivors with moderate heart weakness are at highest risk of sudden cardiac death. Researchers will collect health information and heart imaging over 5 years to find early warning signs.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.